🔎 Trials Near Me

Dachaigh › Melanoma Uveal › New York

Sgrùdaidhean clionaigeach Melanoma Uveal ann an New York

Tha 7 sgrùdaidhean airson Melanoma Uveal a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05607095

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  • Memorial Sloan Kettering Cancer Center, New York
  • Northwell Health, New York
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07804186

Adjuvant Tebentafusp in High Risk Ocular Melanoma

  • Northwell Health -Center for Advanced Medicine, Lake Success
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06246149

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
  • Northwell Health Cancer Institute, New York
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2/3
Gach aois · Gach gnè · Air ùrachadh 2 Gibl 2026 · NCT06581406

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

  • Northwell Health Center for Advanced Medicine, New Hyde Park
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Dùbh 2025 · NCT06121180

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.